ETFChannel.com
AXGN Description — Axogen Inc

Axogen is focused on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. Co.'s platform for peripheral nerve repair features a portfolio of products, including Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; and Axoguard Nerve Connector, a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Co. also provides Axotouch Two-Point Discriminator, which is used to measure the innervation density of any surface area of the skin.

Company Name: 
Axogen Inc
Website: 
www.axogeninc.com
Sector: 
Medical Instruments & Supplies
Number of ETFs Holding AXGN: 
15
Total Market Value Held by ETFs: 
$26,693,513
Total Market Capitalization: 
$296,000,000
% of Market Cap. Held by ETFs: 
9.02%
 ETF   AXGN Weight   AXGN Amount 
 VTI   0.00%   $8,872,531         
 IWM   0.01%   $6,770,059         
 VXF   0.00%   $4,509,978         
 IWO   0.02%   $2,465,881         
 IHI   0.04%   $1,979,072         
 VTWO   0.01%   $1,061,682         
 IWC   0.07%   $623,767         
 VTWG   0.02%   $251,132         
 IWV   0.00%   $75,624         
 QQQS   0.37%   $26,820         
List of all 15 ETFs holding AXGN »
Quotes delayed 20 minutes

Email EnvelopeFree AXGN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Strong Buy (4.00 out of 4)
97th percentile
(ranked higher than approx. 97% of all stocks covered)

Analysts Forecast:
AXGN Price Target

Based on data provided by Zacks Investment Research via Quandl.com

ETFs Holding AXGN | Axogen Inc | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2024, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.